Cwm, LLC Altimmune, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Cwm, LLC holds 6 shares of ALT stock, worth $40. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 224 97.32%

Holding current value

$40

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$5.5 - $8.1 $1,199 - $1,765	-218 Reduced 97.32%	6 $0
Q2 2024 Jul 09, 2024	BUY	$5.91 - $10.23 $1,300 - $2,250	220 Added 5500.0%	224 $1,000
Q1 2024 Apr 05, 2024	BUY	$8.22 - $13.81 $32 - $55	4 New	4 $0
Q1 2022 Apr 21, 2022	SELL	$5.9 - $9.45 $4,572 - $7,323	-775 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$8.69 - $12.48 $2,172 - $3,120	-250 Reduced 24.39%	775 $7,000
Q4 2020 Sep 15, 2021	BUY	$7.84 - $14.22 $1,960 - $3,555	250 Added 32.26%	1,025 $10,000
Q4 2020 Jan 27, 2021	SELL	$7.84 - $14.22 $1,960 - $3,555	-250 Reduced 24.39%	775 $9,000
Q3 2020 Sep 15, 2021	BUY	$9.93 - $33.26 $10,178 - $34,091	1,025 New	1,025 $10,000
Q3 2020 Oct 19, 2020	SELL	$9.93 - $33.26 $10,178 - $34,091	-1,025 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$2.9 - $10.71 $2,972 - $10,977	1,025 New	1,025 $10,000
Q2 2020 Jul 22, 2020	SELL	$2.9 - $10.71 $2,972 - $10,977	-1,025 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$1.69 - $3.8 $1,732 - $3,895	1,025 New	1,025 $10,000
Q1 2020 Apr 28, 2020	SELL	$1.69 - $3.8 $1,732 - $3,895	-1,025 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$1.53 - $2.15 $1,568 - $2,203	1,025 New	1,025 $10,000
Q4 2019 Jan 27, 2020	SELL	$1.53 - $2.15 $1,568 - $2,203	-1,025 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$1.95 - $2.66 $1,998 - $2,726	1,025 New	1,025 $10,000
Q3 2019 Oct 22, 2019	SELL	$1.95 - $2.66 $1,998 - $2,726	-1,025 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$2.19 - $3.4 $2,244 - $3,485	1,025 New	1,025 $10,000
Q2 2019 Jul 31, 2019	SELL	$2.19 - $3.4 $2,244 - $3,485	-1,025 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$2.54 - $4.54 $2,603 - $4,653	1,025 New	1,025 $0

Others Institutions Holding ALT

# of Institutions

190

Shares Held

42.3M

Call Options Held

1.05M

Put Options Held

582K

Black Rock Inc. New York, NY

5.32M
Shares

$36.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.91M
Shares

$33.4 Million
0.0% of portfolio
State Street Corp Boston, MA

3.91M
Shares

$26.6 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

3.22M
Shares

$21.9 Million
0.01% of portfolio
Tang Capital Management LLC San Diego, CA

2.75M
Shares

$18.7 Million
2.23% of portfolio

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $333M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account